Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

BACKGROUND: Oral fluoropyrimidine plus platinum is a standard first-line treatment for advanced gastric cancer (AGC). However, this treatment is problematic for AGC patients with massive ascites or inadequate oral intake. This study aimed at evaluating the efficacy and safety of modified oxaliplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Osumi, Hiroki, Takahari, Daisuke, Chin, Keisho, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Suzuki, Takeshi, Ota, Yumiko, Nakayama, Izuma, Ooki, Akira, Suenaga, Mitsukuni, Shinozaki, Eiji, Yamaguchi, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260191/
https://www.ncbi.nlm.nih.gov/pubmed/30538499
http://dx.doi.org/10.2147/OTT.S184665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260191/
https://www.ncbi.nlm.nih.gov/pubmed/30538499
http://dx.doi.org/10.2147/OTT.S184665

Ejemplares similares